4.8 Article

Study on liver histopathology of chronic HBV infected patients with different normal ALT values

Journal

FRONTIERS IN IMMUNOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.1069752

Keywords

chronic HBV-infection; ALT value; HBV therapy; liver histopathology; clinical indicators

Categories

Funding

  1. Digestive Medical Coordinated Development Center of Beijing Hospitals Authority [XXZ0302, XXT28]
  2. Beijing science and technology commission [Z211100002921059]
  3. High-level Public Health Technical Personnel Training Program of Beijing Municipal Health Commission [2022-3-050]
  4. National Science and Technology Major Project of China [2017ZX10201201-001-006, 2017ZX10201201-002-006, 2018ZX10715-005-003-005]
  5. capital health research and development of special [2022-1-2172]
  6. Beijing Hospitals Authority Clinical Medicine Development [XMLX 202127]
  7. National Key R&D Program of China [2022YFC2603500]

Ask authors/readers for more resources

This study aimed to compare liver histopathological findings in chronic hepatitis B (CHB) patients with different alanine aminotransferase (ALT) normal values to explore the occurrence of liver inflammation. A total of 1474 patients were enrolled, and ALT, HBsAg, and HBeAg status were found to be relevant factors in the occurrence of significant hepatic histopathology.
AimsComparison of liver histopathological findings to explore the occurrence of liver inflammation in patients with chronic hepatitis B (CHB) under different alanine aminotransferase (ALT) normal values. MethodsThe patients who were diagnosed as chronic hepatitis B virus (HBV) infection by liver histopathology at the Department of Pathology, Beijing Ditan Hospital due to clinical difficulty in defining the degree of liver inflammation or fibrosis were retrospectively enrolled from May 2008 to November 2020. Study of the incidence of significant hepatic histopathology in enrolled patients according to different ALT normal values. Using logistic regression to investigate the relevant factors of significant hepatic histopathology. ResultsA total of 1474 patients were enrolled, 56.20% of the patients were male, and the overall patients' age was 36.80 +/- 10.60 years. 39.00% of patients had liver inflammation grade G > 1, 34.70% liver fibrosis stage S > 1, and 48.17% patients had significant hepatic histopathology (G > 1 and/or S > 1). Among patients with normal ALT values, 36.40% and 40.40% had significant hepatic histopathology by American Association for the Study of Liver Diseases (AASLD) criteria and Chinese guideline criteria, respectively, but the difference was not statistically significant (chi(2 =)3.38, P =0.066). In contrast, among patients with abnormal ALT values, 58.90% and 62.20% of patients had significant hepatic histopathology by AASLD criteria and Chinese guideline criteria, respectively, with no significant difference (chi(2 =)2.28, P =0.131). ALT (P <0.001, OR=1.019), hepatitis B surface antigen (HBsAg) (P <0.001, OR=0.665) and hepatitis B e antigen (HBeAg) status (P <0.001, OR=2.238) were relevant factors in the occurrence of significant hepatic histopathology. ALT was positively corelated with grade of inflammation G (r =0.194, P <0.001) and negatively correlated with liver fibrosis stage S (r =-0.066, P =0.021). ConclusionsOur study found no statistically significant differences in the presence of significant hepatic histopathology under the two ALT criteria. ALT, HBsAg and HBeAg status were related to the occurrence of significant hepatic histopathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available